MK-4827 tosylate
| Overview | |
| Catalog # | bs-76572c-10mg |
| Product Name | MK-4827 tosylate |
| Specifications | |
| Storage Buffer | Solid |
| Storage Condition | Stable for 2 years after receipt when stored at -20°C. |
| Target | |
| Product Information | CAS Number: 1038915-73-9 Molecular formula: C19H20N4O . C7H8O3S Molecular weight: 492.6 Purity: >99% (HPLC) Appearance: White to off-white solid. Solubility: Soluble in DMSO or DMF (both 20mg/ml). Sparingly soluble in ethanol (1mg/ml) or water (<1mg/ml). InChiKey: LCPFHXWLJMNKNC-PFEQFJNWSA-N SMILES: NC(C1=CC=CC2=CN(C3=CC=C([C@H]4C[NH2+]CCC4)C=C3)N=C21)=O.CC5=CC=C(S(=O)([O-])=O)C=C5 SMILES: CC1=CC=C(C=C1)S(O)(=O)=O.NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1 |
| Description | MK-4827 is an orally bioavailable inhibitor of poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 (IC50s=3.8 and 2.1nM, respectively). It inhibits the proliferation of cancer cells carrying the breast cancer mutations BRCA1 and BRCA2 in vitro and has efficacy alone against a xenograft of BRCA1-deficient cancer in mice. MK-4827 sensitizes human lung and breast cancer xenografts to radiation in mice.3 Formulations containing MK-4827 are effective against ovarian cancer. |